Flavopiridol (Alvocidib)
Flavopiridol (Alvocidib) competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4, CDK6, and CDK9 with IC50 values in the 20-100 nM range. It is more selective for CDK1, 2, 4, 6, 9 versus CDK7. Flavopiridol is initially found to inhibit EGFR and PKA. Flavopiridol induces autophagy and ER stress. Flavopiridol blocks HIV-1 replication. Phase 1/2.
Trivial name | NSC 649890, HMR-1275, L86-8275 |
Catalog Number | S1230 |
Molecular Formula | C21H20ClNO5 |
CAS# | 146426-40-6 |
Inchi | InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1 |
Inchi Key | BIIVYFLTOXDAOV-YVEFUNNKSA-N |
SMILES | CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O |
Size | 100mg |
Supplier Page | http://www.selleckchem.com/products/Flavopiridol.html |
Additional Information | https://file.selleck.cn/downloads/struct/flavopiridol-chemical-structure-s1230.gif |